22NW, LP

Q3 2025 13F Holdings

  • Location
    seattle, WA
  • Num holdings

    21

  • Value ($000)

    $212,261

  • Date Filed
    11/14/2025
  • Form type
    13F-HR
  • CIK
    0001694297
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
A
ANEB

ANEBULO PHARMACEUTICALS INC

COM
034569103
$38.67M
18 %

15,467,300

F
FSTR

FOSTER L B CO

COM
350060109
$35.39M
17 %

1,313,121

L
LDE

LIFECORE BIOMEDICAL INC

COM
514766104
$20.15M
10 %

1,254

---

NEKTAR THERAPEUTICS

COM NEW
640268306
$18.84M
9 %

331,115

---

STONERIDGE INC

COM
86183P102
$16.04M
8 %

2,105,600

M
MLYS

MINERALYS THERAPEUTICS INC

COM
603170101
$13.59M
6 %

358,325

R
RGNX

REGENXBIO INC

COM
75901B107
$8.91M
4 %

923,679

C
CULP

CULP INC

COM
230215105
$8.29M
4 %

1,859,061

R
RZLT

REZOLUTE INC

COM NEW
76200L309
$7.71M
4 %

820,653

D
DHX

DHI GROUP INC

COM
23331S100
$5.66M
3 %

2,036,988

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 21